Resarchers discover how CHPs vividly display collagen turnover during cancer development.
info@3helix.com
Resarchers discover how CHPs vividly display collagen turnover during cancer development.
Studying the destruction of bone collagen and increased fibrosis in Multiple Myeloma is crucial for researchers as it provides insights into disease mechanisms, helps identify new therapeutic targets, and aids in developing treatments to mitigate bone damage and organ fibrosis. Collagen Hybridizing Peptides can aid researchers in quantifying osteolytic lesions resulting from Multiple Myeloma and monitoring fibrotic activity throughout the body. By using CHPs, researchers can gain precise, real-time data on collagen changes, improving their understanding of MM pathology and enhancing their ability to monitor treatment efficacy, ultimately leading to better patient outcomes.
Collagen Hybridizing Peptides open the door for similar research in other cancer types:
If you don't see the specific condition you're studying, it may be because we have yet to validate it; however, we are confident that Collagen Hybridizing Peptides will be effective in other osteologic conditions.
We highly recommend using our In Vivo CHPs to investigate these conditions
Our In Vivo CHPs are conjugated with sCy 7.5 for near-IR detection. Contact us for customized conjugates.
Contact UsThanks for subscribing!
This email has been registered!